Compare AVPT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVPT | INSP |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | United States |
| Employees | 3443 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | 2018 |
| Metric | AVPT | INSP |
|---|---|---|
| Price | $13.43 | $63.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | $16.64 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 1.6M | 416.3K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $25.00 | $8.02 |
| Revenue Next Year | $19.63 | $8.11 |
| P/E Ratio | $1,348.94 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $8.84 | $38.91 |
| 52 Week High | $16.77 | $147.03 |
| Indicator | AVPT | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 60.61 |
| Support Level | $12.92 | $56.50 |
| Resistance Level | $13.71 | $66.21 |
| Average True Range (ATR) | 0.41 | 2.43 |
| MACD | -0.03 | -0.17 |
| Stochastic Oscillator | 49.84 | 77.91 |
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.